相关实验视频

Updated: Jun 7, 2025

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

通过激活SIRT1/FoxO1轴,通过向microRNA-132来防止香烟烟雾引起的慢性阻塞性肺病

Qin Shen¹, Jing Chen¹, Suzhen Yang¹

¹Department of Respiratory Medicine, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University) Changsha 410005, Hunan, P. R. China.

American journal of translational research

|November 15, 2024

概括

抑制微RNA-132 (miR-132) 可以通过恢复小鼠SIRT1/FoxO1信号传递来治疗慢性阻塞性肺病 (COPD). 这项研究揭示了miR-132在COPD病变发生过程中的作用.

科学领域:

肺部医学肺部医学
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

慢性阻塞性肺病 (COPD) 是一种进展性肺病,其特征是持续的呼吸道症状.
香烟烟雾 (CS) 是COPD的主要病因因素,导致炎症,亡和组织损伤.
微RNAs (miRNAs) 正在成为包括COPD在内的各种疾病的关键调节者.

研究的目的:

为了阐明miR-132在香烟烟雾引起的COPD小鼠模型中的作用.
调查针对miR-132.2的潜在治疗效果.
探索SIRT1/FoxO1信号通路的参与.

主要方法:

在C57BL/6J小鼠中,通过8周的香烟烟雾 (CS) 暴露诱导了COPD.
一个miR-132淘汰赛小鼠模型被用于评估其在CS诱导的COPD中的特定功能.
评估了肺组织亡,组织病理学和肺功能.

主要成果:

在COPD小鼠的肺部,miR-132的表达显著升高.
耗尽miR-132改善了肺功能,改善了组织形态,并减少了亡.
miR-132淘汰赛小鼠表现出恢复的SIRT1和FoxO1表达,这表明miR-132抑制SIRT1.

结论:

miR-132在CS诱导的COPD的发病过程中起着至关重要的作用.
抑制miR-132证明了COPD的治疗潜力.
SIRT1/FoxO1轴是COPD中由miR-132调节的关键下游途径.

关键词:

慢性阻塞性肺病是一种慢性阻塞性肺病.在SIRT1/FoxO-1轴上微型RNA-132是什么意思

更多相关视频

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Published on: July 12, 2024

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...